Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesCTUsing GPT‑4o with CT exams helps diagnose ovarian cancer earlierEarly detection of ovarian cancer is a persistent challenge, with more than half still diagnosed at metastatic stages.Womens ImagingSurvey: Nearly 4 out of 5 practices short on breast imagersRadiation Oncology/TherapyPooled evidence: Lu-177 PSMA-617 vs. established therapies in mCRPCMRICardiac MRI-based ML model predicts MACE risk for STEMI patientsSponsor ContentHow Agentic AI Is Transforming Radiology Ops